Skip to content
HomeMedia CenterPress releases FinancialJohnson & Johnson to Host
Investor Conference Call on First-Quarter Results

Johnson & Johnson to Host
Investor Conference Call on First-Quarter Results

Share Article
share to

New Brunswick, NJ (March 19, 2019) - Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, April 16th, to review first-quarter results. Joseph J. Wolk, Executive Vice President, Chief Financial Officer and Christopher DelOrefice, Vice President, Investor Relations will host the call. The question and answer portion of the call will also include the following executives: Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices; Thibaut Mongon, Executive Vice President, Worldwide Chairman, Consumer and Jennifer Taubert, Executive Vice President, Worldwide Chairman, Pharmaceuticals.

Investors and other interested parties can access the webcast/conference call in the
following ways:

  • By telephone: for both “listen-only” participants and those financial analysts who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 877-869-3847. For participants outside the U.S., the dial-in number is 201-689-8261.
  • A replay of the conference call will be available until approximately 12:00 a.m. on April 24, 2019. The replay dial-in number for U.S. participants is 877-660-6853. For participants outside the U.S., the replay dial-in number is 201-612-7415. The replay conference ID number for all callers is 13688797.
  • The press release will be available at approximately 6:45 a.m. (Eastern Time) the morning of the conference call.

About Johnson & Johnson
At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest and most broadly-based health care company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.

###

Press Contacts:

Ernie Knewitz
(732) 524-6623
(917) 697-2318 (M)

Cristal Downing
(732) 524-3283
(908) 616-8833 (M)

Investor Contacts:

Christopher DelOrefice
(732) 524-2955

Lisa Romanko
(732) 524-2034

You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.